Computerised assistance for warfarin dosage - Effects on treatment quality

European Journal of Internal Medicine

Volumn 23, Issue 8, 2012, Pages 742-744

  Dimberg, Ivar ^a   Grzymala Lubanski, Bartosz ^b   Hägerfelth, Anette ^c   Rosenqvist, Mårten ^a   Svensson, Peter ^d   Själander, Anders ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Tiohundra AB ^*  (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Anticoagulation; Atrial fibrillation; Warfarin

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; AURICULA SYSTEM; AUTOMATION; CARDIOVERSION; COHORT ANALYSIS; COMPUTER ASSISTED DRUG THERAPY; COMPUTERIZED PROVIDER ORDER ENTRY; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTICENTER STUDY; RETROSPECTIVE STUDY; TIME IN THERAPEUTIC RANGE; TREATMENT DURATION; TREATMENT OUTCOME; WEB BROWSER;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG MONITORING; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; QUALITY OF HEALTH CARE; REGISTRIES; RETROSPECTIVE STUDIES; SWEDEN; THERAPY, COMPUTER-ASSISTED; THROMBOSIS; WARFARIN;

EID: 84869085735     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.07.011     Document Type: Article

References (13)

1. D.E. Singer, G.W. Albers, J.E. Dalen, A.S. Go, J.L. Halperin, and W.J. Manning Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 429S 456S (Pubitemid 39302603)
2. The National board of health and welfare, Sweden. Statistical database of medical drugs, statistics for december 2011. www.socialstyrelsen.se/statistics
3. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867 (Pubitemid 351650486)
4. J. Wallvik, A. Själander, L. Johansson, Ö. Bjuhr, and J.H. Jansson Bleeding complications during warfarin treatment in primary healthcare centers compared with anticoagulation clinics Scand J Prim Health Care 25 2007 123 128 (Pubitemid 46752224)
5. E.J. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696 (Pubitemid 46842784)
6. A. Själander, G. Engström, E. Berntorp, and P. Svensson Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population J Intern Med 254 2003 434 438 (Pubitemid 37346626)
7. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briët A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239 (Pubitemid 23069000)
8. W.L. Baker, D.A. Cios, S.D. Sander, and C.I. Coleman Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States J Manag Care Pharm 15 2009 244 252
9. S.J. Connolly, J. Pogue, J. Eikelboom, G. Flaker, P. Commerford, and M.G. Franzosi Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range Circulation 118 2008 2029 2037
10. Y. Wan, C. Heneghan, R. Perera, N. Roberts, J. Hollowell, and P. Glasziou Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review Circ Cardiovasc Qual Outcomes 1 2008 84.91
11. L. Wallentin, S. Yusuf, M.D. Ezekowitz, M. Alings, M. Flather, M.G. Franzosi, P. Pais, A. Dans, J. Eikelboom, J. Oldgren, J. Pogue, P.A. Reilly, S. Yang, S.J. Connolly, and RE-LY investigators Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lancet 376 2010 975 983
12. M. Wieloch, A. Själander, V. Frykman, M. Rosenqvist, N. Eriksson, and P.J. Svensson Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA Eur Heart J 32 2011 2282 2289
13. S. Jowett The cost-effectiveness of computer-assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicenter study J Thromb Haemost 9 2009 1482 1490